These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27698942)

  • 21. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
    Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
    Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib.
    Zhang CC; Yan Z; Giddabasappa A; Lappin PB; Painter CL; Zhang Q; Li G; Goodman J; Simmons B; Pascual B; Lee J; Levkoff T; Nichols T; Xie Z
    Cancer Med; 2014 Jun; 3(3):462-71. PubMed ID: 24573979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and
    Gross J; Palmowski K; Doleschel D; Rix A; Gremse F; Verburg F; Mottaghy FM; Kiessling F; Lederle W; Palmowski M
    Contrast Media Mol Imaging; 2021; 2021():6676337. PubMed ID: 34007252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
    Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
    Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients.
    Gao S; Wu H; Li W; Zhao S; Teng X; Lu H; Hu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2029-37. PubMed ID: 26153145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
    Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
    J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.
    Ma Y; Xu W; Bai R; Li Y; Yu H; Yang C; Shi H; Zhang J; Li J; Wang C; Xiao J
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):199-205. PubMed ID: 27604790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [
    Tanguy J; Goirand F; Bouchard A; Frenay J; Moreau M; Mothes C; Oudot A; Helbling A; Guillemin M; Bonniaud P; Cochet A; Collin B; Bellaye PS
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3058-3074. PubMed ID: 33580818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.
    Revheim ME; Winge-Main AK; Hagen G; Fjeld JG; Fosså SD; Lilleby W
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):339-43. PubMed ID: 21134733
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Grkovski M; Emmas SA; Carlin SD
    J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT.
    Revheim ME; Røe K; Bruland ØS; Bach-Gansmo T; Skretting A; Seierstad T
    Mol Imaging Biol; 2011 Dec; 13(6):1234-40. PubMed ID: 21161686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized
    Ravoori MK; Singh SP; Lee J; Bankson JA; Kundra V
    Radiology; 2017 Dec; 285(3):830-838. PubMed ID: 28707963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET.
    Guo N; Zhang F; Zhang X; Guo J; Lang L; Kiesewetter DO; Niu G; Li Q; Chen X
    Mol Imaging Biol; 2015 Dec; 17(6):865-73. PubMed ID: 25896816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
    Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM
    J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers 18F-Alfatide and 18F-FDG: A Comparative Analysis.
    Wei YC; Hu X; Gao Y; Fu Z; Zhao W; Yu Q; Wang S; Zhu S; Li J; Yu J; Yuan S
    PLoS One; 2015; 10(9):e0136195. PubMed ID: 26352404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
    Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
    J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.
    Zhou LN; Wu N; Liang Y; Gao K; Li XY; Zhang LF
    World J Surg Oncol; 2015 Mar; 13():111. PubMed ID: 25888731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stratification of 18F-labeled PET imaging agents for the assessment of antiangiogenic therapy responses in tumors.
    Goggi JL; Bejot R; Moonshi SS; Bhakoo KK
    J Nucl Med; 2013 Sep; 54(9):1630-6. PubMed ID: 23907757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
    Viel T; Talasila KM; Monfared P; Wang J; Jikeli JF; Waerzeggers Y; Neumaier B; Backes H; Brekka N; Thorsen F; Stieber D; Niclou SP; Winkeler A; Tavitian B; Hoehn M; Bjerkvig R; Miletic H; Jacobs AH
    J Nucl Med; 2012 Jul; 53(7):1135-45. PubMed ID: 22689925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.